Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene

被引:114
作者
Berrendero, F
Mendizábal, V
Robledo, P
Galeote, L
Bilkei-Gorzo, A
Zimmer, A
Maldonado, R [1 ]
机构
[1] Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Lab Neurofarmacol, Barcelona 08003, Spain
[2] Inst Municipal Invest Med, Pharmacol Res Unit, E-08003 Barcelona, Spain
[3] Univ Bonn, Dept Psychiat, Mol Neurobiol Lab, D-53105 Bonn, Germany
关键词
nicotine; antinociception; reward; dependence; enkephalin; knock-out mice;
D O I
10.1523/JNEUROSCI.3008-04.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
It has been shown previously that the endogenous opioid system may be involved in the behavioral effects of nicotine. In the present study, the participation of endogenous enkephalins on nicotine responses has been investigated by using preproenkephalin knock-out mice. Acute nicotine-induced hypolocomotion remained unaffected in these mice. In contrast, antinociception elicited in the tail-immersion and hot-plate tests by acute nicotine administration was reduced in mutant animals. The rewarding properties of nicotine were then investigated using the place-conditioning paradigm. Nicotine induced a conditioned place preference in wild-type animals, but this effect was absent in knock-out mice. Accordingly, in vivo microdialysis studies revealed that the enhancement in dopamine extracellular levels in the nucleus accumbens induced by nicotine was also reduced in preproenkephalin-deficient mice. Finally, the somatic expression of the nicotine withdrawal syndrome precipitated in nicotine-dependent mice by mecamylamine was significantly attenuated in mutant animals. In summary, the present results indicate that endogenous opioid peptides derived from preproenkephalin are involved in the antinociceptive and rewarding properties of nicotine and participate in the expression of physical nicotine dependence.
引用
收藏
页码:1103 / 1112
页数:10
相关论文
共 59 条
[51]   NALTREXONE, SMOKING-BEHAVIOR AND CIGARETTE WITHDRAWAL [J].
SUTHERLAND, G ;
STAPLETON, JA ;
RUSSELL, MAH ;
FEYERABEND, C .
PSYCHOPHARMACOLOGY, 1995, 120 (04) :418-425
[52]   Naloxone inhibits nicotine-induced receptor current and catecholamine secretion in bovine chromaffin cells [J].
Tomé, AR ;
Izaguirre, V ;
Rosário, LM ;
Ceña, V ;
González-García, C .
BRAIN RESEARCH, 2001, 903 (1-2) :62-65
[53]  
TRIPATHI HL, 1982, J PHARMACOL EXP THER, V221, P91
[54]  
Watkins SS, 2000, J PHARMACOL EXP THER, V292, P1053
[55]   Naltrexone administration affects ad libitum smoking behavior [J].
Wewers, ME ;
Dhatt, R ;
Tejwani, GA .
PSYCHOPHARMACOLOGY, 1998, 140 (02) :185-190
[56]   The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats [J].
Wewers, ME ;
Dhatt, RK ;
Snively, TA ;
Tejwani, GA .
BRAIN RESEARCH, 1999, 822 (1-2) :107-113
[57]   Presynaptic nicotinic ACh receptors [J].
Wonnacott, S .
TRENDS IN NEUROSCIENCES, 1997, 20 (02) :92-98
[58]   Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception [J].
Zarrindast, MR ;
Pazouki, M ;
NassiriRad, S .
PHARMACOLOGY & TOXICOLOGY, 1997, 81 (05) :209-213
[59]   Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse [J].
Zocchi, A ;
Girlanda, E ;
Varnier, G ;
Sartori, I ;
Zanetti, L ;
Wildish, GA ;
Lennon, M ;
Mugnaini, M ;
Heidbreder, CA .
SYNAPSE, 2003, 50 (04) :293-302